PATENT CLAIM ANALYSIS

Application Number: 15744737
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "139100"]

Abstract:
Provided are anti-PD-L1 antibodies or fragments thereof. The antibodies or fragments thereof specifically bind to the immunoglobulin C domain of the PD-L1 protein. In various example, the antibodies or fragments thereof include a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and infectious diseases are also provided.

Claim (Index 10):
The antibody or fragment thereof of  claim 1 , comprising a light chain variable region comprising one or more amino acid residues selected from the group consisting of:\n (a) Ser at position 22, (b) Gln at position 42, (c) Ser at position 43, (d) Asp at position 60, and (e) Thr at position 63, according to Kabat numbering, and combinations thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 2.27273
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15328232', '15328225', '13802172', '15636610', '12663950']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7111235297439051
- 35 USC 102 Novelty (BERT): 0.5457196219074953
- Combined Prediction Score: 0.6945831389602642
- Mean Citation Score: 387.01603400000016
- Max Citation Score: 391.06833
- Similarity Product: 302.96708649703146

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test